ScholarWorks@SUNGKYUNKWAN UNIVERSITY: KIM, TAE HYUK

Detailed Information

KIM, TAE HYUK (김태혁)

Medicine (Medicine)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

thyroid cancer:4||Prognosis:4||papillary thyroid carcinoma:3||Differentiated thyroid cancer:3||Ultrasonography:3||disease:2||smoking:2||lymph nodes:2||Korea:2||Antithyroid agents:2||metastasis:2||Mortality:2||fineneedle aspiration:2||thyroid neoplasm:2||TERT promoter:2||Thyroid neoplasms:2||Recurrence:2||TSH suppression:2||ultrasonography:2||hypothyroidism:2||Graves&apos:2||Lymph node ratio:2||radioactive iodine therapy:2||active surveillance:2||age:2||Inherited thyroxinebinding globulin deficiency:1||Iodinesufficient area:1||KTIRADS:1||Kidney failure:1||Largest metastatic lymph node size:1||Lateral neck metastasis:1||Lymphocyte:1||Medullary thyroid carcinoma:1||Minimal N1b:1||Mutation:1||Mutation rate:1||NIFTP:1||Neoplasm metastasis:1||Neutrophil:1||Neutrophiltolymphocyte ratio:1||Nonimmunerelated hypothyroidism:1||Nondiagnostic:1||Oncologic outcome:1||Osteoporosis:1||Papillary thyroid carcinoma:1||Parkinson's disease:1||Pediatric papillary thyroid carcinoma:1||Preoperative identification:1||Radioactive iodine:1||Radioactive iodine therapy:1||Radiotherapy:1||Recombinant human thyrotropin:1||Renal function:1||Reporting and data system (TIRADS):1||SERPINA7 protein, human:1||Screening interval:1||Serum selenium:1||South Korea:1||Subtyping:1||TNM staging:1||Tall cell variant:1||Telomerase reverse transcriptase:1||Thyroid:1||Thyroid cancer:1||Thyroid function:1||Thyroid hormone withdrawal:1||Thyroid imaging:1||Thyroid neoplasm:1||Thyroxinebinding globulin:1||Thyroxinebinding globulin deficiency:1||Treatment outcome:1||Unsatisfactory:1||Urine iodine:1||Urine selenium:1||alcohol consumption:1||alcohol intake:1||antithyroid drug (ATD):1||atrial fibrillation:1||bidirectionality:1||calcitonin:1||cancer:1||childhood:1||chronic:1||clinical decision making:1||clinical decisionmaking:1||cohort study:1||core needle biopsy:1||differentiated thyroid cancer:1||dyslipidemia:1||epidemiology:1||extranodal extension:1||follicular thyroid carcinoma:1||follicular variant of papillary thyroid carcinoma:1||gender:1||graves’ disease:1||incidence:1||increase:1||interaction:1||iodinereplete area:1||lenvatinib:1||lifestyle change:1||lymph node:1||lymph node excision:1||medullary thyroid carcinoma:1||metabolic:1||molecular diagnostic technique:1||multifocality:1||osteoporosis:1||overall survival:1||oxcarbazepine:1||papillary thyroid microcarcinoma:1||pediatric patients:1||populationbased study:1||progression:1||prospective study:1||radioactive iodine treatment:1||radioiodinerefractory differentiated thyroid carcinoma:1||recurrence:1||riskstratification system:1||salvage treatment:1||sorafenib:1||success rate:1||surgery:1||thyroglobulin:1||thyroid:1||thyroid function:1||thyrotropin receptor antibody:1||thyrotropinbinding inhibitory immunoglobulins:1||total thyroidectomy:1||tumor growth:1||tumor volume doubling time:1||ultrasound:1||APC gene mutation:1||βcatenin:1||ATA:1||Anaplastic thyroid carcinoma:1||BMD testing:1||BMI:1||BRAF:1||BRAFprevalent population:1||Bone density:1||Bone diseases:1||CMVPTC:1||Cause of death:1||Computed tomography:1||Core needle biopsy:1||Distant metastasis:1||Epidemiology:1||Excess iodine:1||Extensive N1b:1||FAP:1||Fine needle aspiration:1||Fineneedle aspiration:1||Follicular variant papillary thyroid carcinoma:1||Graves disease:1||Graves' disease:1||Grave’s disease:1||Hyperthyroidism:1||

STATISTICS: Total View :5,283,795; Today View :1,592

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE